Protara Therapeutics, Inc. Restricted Cash, Current
Protara Therapeutics, Inc. (TARA) had Restricted Cash, Current of $50.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2022-03-09
- 2021-03-31: Restricted Cash, Current $50.00K.
- 2020-12-31: Restricted Cash, Current $50.00K.
- 2020-09-30: Restricted Cash, Current $50.00K.
- 2020-06-30: Restricted Cash, Current $50.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2021-03-31 | $50.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $50.00K 10-K · filed 2022-03-09 |
| 2020-09-30 | $50.00K 10-Q · filed 2021-11-04 |
| 2020-06-30 | $50.00K 10-Q · filed 2021-08-05 |
| 2020-03-31 | $50.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $50.00K 10-K · filed 2020-03-20 |
| 2019-09-30 | $22.00K 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |